Highlights
NASDAQ: GNOM       Global X Genomics & Biotechnology ETF
Last Price Today's Change   Day's Range   Trading Volume
16.52   +0.11 (0.67%)  16.41 - 16.87  10,391

Overview

 
Avg Volume (4 weeks):23,000
4 Weeks Range:14.872 - 17.36
4 Weeks Price Volatility (%):
66.24%
52 Weeks Range:10.16 - 17.36
52 Weeks Price Volatility (%):
88.33%
Average Price Target: 3.00
Price Target Upside/Downside: -13.52

Headlines



No recent Headlines for this stock.


Business Background

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3156  2699  216  2889 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TOPS 0.225+0.073 
 AAL 18.59+1.87 
 SHIP 0.169+0.032 
 HTZ 2.57+1.07 
 LK 5.51+1.46 
 OAS 1.26+0.703 
 F 7.34+0.77 
 XSPA 2.37+0.47 
 GE 7.88+0.14 
 UAL 42.405+3.305 
Partners & Brokers